358 related articles for article (PubMed ID: 23041167)
1. Very long-term outcomes following drug-eluting stent implantation for unprotected left main coronary artery stenosis: a single center experience.
Ielasi A; Latib A; Chieffo A; Takagi K; Mussardo M; Davidavicius G; Godino C; Carlino M; Montorfano M; Colombo A
Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):24-33. PubMed ID: 23041167
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
3. Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry.
Mylotte D; Meftout B; Moynagh A; Vaquerizo B; Darremont O; Silvestri M; Louvard Y; Leymarie JL; Morice MC; Lefèvre T; Garot P
EuroIntervention; 2012 Dec; 8(8):970-81. PubMed ID: 23014945
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
Gómez-Hospital JA; Gomez-Lara J; Rondan J; Homs S; Lozano Martínez-Luengas I; Ferreiro JL; Roura G; Maristany J; Teruel L; Carro A; Avanzas P; Jara P; Esplugas E; Moris C; Cequier A
Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):530-7. PubMed ID: 22521483
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
Park KW; Kang SH; Park KH; Choi DH; Lee HY; Kang HJ; Cho YS; Yeon TJ; Chung WY; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
Int J Cardiol; 2011 Aug; 151(1):89-95. PubMed ID: 20605240
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
7. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
[TBL] [Abstract][Full Text] [Related]
8. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
10. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
11. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Gonzalo N; Cook S; Marra S; Moretti C; De Servi S; Palacios IF; Windecker S; van Domburg R; Colombo A; Sheiban I; Serruys PW
Int J Cardiol; 2009 Sep; 137(1):16-21. PubMed ID: 18687481
[TBL] [Abstract][Full Text] [Related]
12. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of patients with unprotected left main bifurcation lesions treated with 2-stent techniques.
Pei HJ; Sui YG; Wu YJ; Yang YJ; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Yuan JQ; Chen J; Liu HB; You SJ; Gao RL
Chin Med J (Engl); 2013 Jul; 126(13):2409-13. PubMed ID: 23823809
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial.
Diletti R; Garcia-Garcia HM; Bourantas CV; van Geuns RJ; Van Mieghem NM; Vranckx P; Zhang YJ; Farooq V; Iqbal J; Wykrzykowska JJ; de Vries T; Swart M; Teunissen Y; Negoita M; van Leeuwen F; Silber S; Windecker S; Serruys PW;
Heart; 2013 Sep; 99(17):1267-74. PubMed ID: 23800571
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease.
Lee HJ; Yu CW; Hwang HK; Choi RK; Park JS; Li H; Ro YM
Coron Artery Dis; 2013 Nov; 24(7):542-8. PubMed ID: 23994880
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term outcomes of drug-eluting stent implantations in aorto-ostial, left anterior descending artery-ostial, and nonostial lesions.
Hsieh IC; Chen CC; Chang SH; Hsieh MJ; Wang CY; Lee CH; Lin FC
Catheter Cardiovasc Interv; 2013 Nov; 82(5):727-34. PubMed ID: 23592601
[TBL] [Abstract][Full Text] [Related]
19. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
